Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen

Vermeij, R.; Leffers, N.; Melief, C.J.; Daemen, T.; Nijman, H.W. (2012)

Article / Letter to editor

• Immunotherapy
• vaccine
• epithelial ovarian cancer
• tumor antigen
• p53
• lymphocyte
• immunization
• clinical trial

• All authors: Vermeij, R.; Leffers, N.; Melief, C.J.; Daemen, T.; Nijman, H.W.
• Date: 2012-08-31
• Journal: Current Pharmaceutical Design
• Volume: 18
• Issue: 25
• Pages: 3804 - 3811
• DOI: doi:10.2174/138161212802002805